Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adenoma
17%
Autoimmune Disease
16%
Biological Product
26%
Bleeding
15%
Capsule Endoscopy
16%
Cohort Analysis
45%
Colectomy
25%
Colitis
20%
Colorectal Carcinoma
18%
COVID-19
25%
Crohn's Disease
64%
Deep Learning Model
20%
Disease Course
17%
Endoscopic Mucosal Resection
20%
Endoscopic Submucosal Dissection
33%
Endoscopic Surgery
20%
Esophagus
16%
Forced Expiratory Volume
16%
Hazard Ratio
33%
Inflammatory Bowel Disease
70%
Infliximab
26%
Intestine Injury
16%
Long-Term Outcome
38%
Lung Cancer
16%
Mesenchymal Stem Cell
16%
Neoplasm
48%
Neuroendocrine Carcinoma
16%
Neuroendocrine Tumor
16%
Non Erosive Reflux Disease
16%
Non Small Cell Lung Cancer
16%
Nonsteroid Antiinflammatory Agent
16%
Odds Ratio
46%
Patient with Crohn's Disease
39%
Patient with Inflammatory Bowel Disease
50%
Patient with Ulcerative Colitis
28%
Polyp
26%
Pregnant Woman
16%
Prevalence
34%
Prognostic Factor
25%
Recurrent Disease
33%
Reflux Esophagitis
25%
Retrospective Cohort Study
18%
Retrospective Study
20%
Signet Ring Cell Carcinoma
16%
Squamous Cell Carcinoma
20%
Tonsil
16%
Treatment Outcome
17%
Tumor Necrosis Factor
26%
Ulcerative Colitis
100%
Venous Thromboembolism
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
8%
Adalimumab
9%
Adverse Event
15%
Anti-Inflammatory Drug
9%
Benzoxazole Derivative
8%
Biological Product
9%
Bleeding
8%
C Reactive Protein
9%
Ciclosporin
8%
Cohort Study
9%
Colitis
60%
Crohn's Disease
23%
Cytokine
20%
Dextran Sulfate
29%
Dextran Sulfate Sodium-Induced Colitis
10%
Disease Activity
22%
Disease Course
7%
End Stage Renal Disease
8%
Enteropathy
8%
Filgotinib
6%
Helicobacter Infection
8%
Helicobacter Pylori
8%
Inflammatory Bowel Disease
41%
Infliximab
10%
Interleukin 1
8%
Interleukin 10
6%
Interleukin 17
5%
Interleukin 6
10%
Intestine Injury
8%
Janus Kinase
6%
Janus Kinase Inhibitor
10%
Lung Cancer
8%
Messenger RNA
10%
Mouse Model
10%
Murine
26%
Neoplasm
5%
Non Small Cell Lung Cancer
8%
Non-Steroidal Anti-Inflammatory Drug
8%
Phosphate Buffered Saline
5%
Remission
20%
Retrospective Study
9%
Steroids
10%
Therapeutic Effect
12%
Tofacitinib
12%
Troponin T
8%
Tumor Necrosis Factor
24%
Tumor Necrosis Factor Inhibitor
16%
Ulcerative Colitis
40%
Upadacitinib
8%
Vaccination
8%
Immunology and Microbiology
Adalimumab
8%
Autoimmune Disease
16%
Biological Product
9%
C-Reactive Protein
9%
Cardiac Troponin
8%
Colitis
70%
Colon
16%
Colorectal Carcinoma
18%
COVID-19
25%
Crohn's Disease
28%
Electron Microscopy
8%
Fatty Acid
8%
Forced Expiratory Volume
8%
Herpes Zoster
8%
Infection
19%
Inflammatory Bowel Disease
39%
Infliximab
9%
Interleukin 6
5%
Lung
8%
Mesenchymal Stem Cell
66%
Morphology
8%
Murine
17%
Prevalence
10%
Programmed Death 1 Ligand 1
8%
T Cell
8%
Tonsil
66%
Ulcerative Colitis
33%
